Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Campaign to Increase Compliance with Take-Home Colorectal Screening Test

By HospiMedica staff writers
Posted on 11 Apr 2008
A novel campaign has been launched help increase compliance with take-home colorectal screening tests. More...
The campaign aims to break down barriers to compliance with fecal occult blood tests and increase screening with convenient take-home screening tools. The goal of the new campaign is to have five million people complete their annual testing over the next five years.

In the United States, nearly 60 % of women have an annual Pap test (for cervical cancer) and as many as 79 % of men receive prostate-specific antigen (PSA) screening every year for prostate cancer. In one randomized clinical study, only 31 % of patients (n = 1818) completed an at-home colorectal screening test. Despite the availability of these convenient and effective diagnostic tests, nearly 150,000 men and women in the United States will be diagnosed with colorectal cancer this year, and one-third of these patients will ultimately succumb to the disease. When found early and treated, the five-year relative survival rate for colon cancer is 90%, but less than 40% of colorectal cancers are found early.

Fecal occult blood tests (FOBTs), including the newer fecal immunochemical tests (FITs), detect blood in the stool that might indicate colorectal cancer or other lower gastrointestinal diseases. These screening tests help identify individuals that are candidates for colonoscopy, even if they do not have overt symptoms of colorectal cancer. This may mean the disease is in its early, more treatable stages, or that they may have precancerous polyps that can be removed during colonoscopy.

Quest Diagnostics (Madison, NJ, USA) is launching the campaign at the end of Cancer Awareness Month "because we want people to remember that this disease strikes every day of every month,” said Stephen C. Suffin, M.D., the company's clinical pathologist and interim chief laboratory officer. "Our Challenge is designed to encourage people 50 and over and those at risk to complete annual screening with American Cancer Society [ACS] recommended tests, such as the FDA-[U.S. Food and Drug Administration]-approved, InSure FIT test and its painless, noninvasive Blue-Brush Method.”

The Challenge urges individuals to talk to their healthcare providers about annual colorectal cancer screening using the InSure FIT take-home test, developed by Quest, and in turn, to challenge friends and family members to "have the guts” to get screened, too. Challenge participants can also send an attention-grabbing "Happy, Healthy Colon” e-card to friends and relatives as a reminder to be screened annually. Medical professionals can access the latest scientific data on InSure FIT, up-to-date colorectal cancer screening guidelines and resources, and patient education materials that can help guide discussions with their patients about colorectal cancer screening.

Quest Diagnostics is a provider of diagnostic testing, information, and services that patients and doctors need to make better healthcare decisions. The company offers access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its medical and scientific staff.


Related Links:
Quest Diagnostics

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Monitor/Defibrillator
Zenix
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.